The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 22, 2019

Primary Completion Date

March 15, 2021

Study Completion Date

March 15, 2021

Conditions
Atopic DermatitisAtopic Eczema
Interventions
DRUG

Betnovate, betamethasone dipropionate ointment 0.1% and placebo

Explore the systemic effects of Betnovate

DRUG

Protopic, tacrolimus ointment 0.1%

Compare the systemic effects of Betnovate to Protopic

Trial Locations (1)

2900

Department of Dermatology and Allergy, Hellerup

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

LEO Pharma

INDUSTRY

lead

Jacob Thyssen

OTHER